Abstract
Gut microbes are now considered as key partners involved in human physiology. Data have shown that microbes contribute to regulate energy, lipid, and glucose homeostasis through several mechanisms. Among them, the role of pathogen-associated molecular pattern and bacterial metabolites has been proposed (for example, metabolic endotoxemia and bioactive lipids). This short review, briefly discusses the role of the gut barrier as well as the impact of both the innate immune system and bioactive molecules (for example, endocannabinoids, cytochrome P450 derived arachidonic acids compounds) in the framework of gut microbes and cardiometabolic disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI . Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915–1920.
Cerf-Bensussan N, Gaboriau-Routhiau V . The immune system and the gut microbiota: friends or foes? NatRevImmunol 2010; 10: 735–744.
Dhurandhar NV, Geurts L, Atkinson RL, Casteilla L, Clement K, Gerard P et al. Harnessing the beneficial properties of adipogenic microbes for improving human health. Obes Rev 2013; 14: 721–735.
Sender R, Fuchs S, Milo R . Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 2016; 164: 337–340.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59–65.
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635–1638.
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355–1359.
Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500: 541–546.
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731–16736.
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013; 110: 9066–9071.
Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R et al. Human genetics shape the gut microbiome. Cell 2014; 159: 789–799.
Cani PD, Everard A . Talking microbes: When gut bacteria interact with diet and host organs. Mol Nutr Food Res 2016; 60: 58–66.
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761–1772.
Cani PD . Metabolism in 2013: The gut microbiota manages host metabolism. Nature Rev Endocrinol 2014; 10: 74–76.
Tilg H, Kaser A . Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121: 2126–2132.
Tremaroli V, Backhed F . Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489: 242–249.
Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC et al. Energy intake is associated with endotoxemia in apparently healthy men. AmJClinNutr 2008; 87: 1219–1223.
Lassenius MI, Pietilainen KH, Kaartinen K, Pussinen PJ, Syrjanen J, Forsblom C et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011; 34: 1809–1815.
Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V . Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011; 34: 392–397.
Cani PD, Possemiers S, Van de WT, Guiot Y, Everard A, Rottier O et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091–1103.
Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C et al. Endocannabinoids—at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 2016; 12: 133–143.
Gummesson A, Carlsson LM, Storlien LH, Backhed F, Lundin P, Lofgren L et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (SilverSpring) 2011; 19: 2280–2282.
Casselbrant A, Elias E, Fandriks L, Wallenius V . Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis 2014; 11: 45–53.
Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 2014; 87: 357–367.
Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y . Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract 2014; 106: 312–318.
Jayashree B, Bibin YS, Prabhu D, Shanthirani CS, Gokulakrishnan K, Lakshmi BS et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 2014; 388: 203–210.
Horton F, Wright J, Smith L, Hinton PJ, Robertson MD . Increased intestinal permeability to oral chromium (51 Cr) -EDTA in human Type 2 diabetes. Diab Med 2014; 31: 559–563.
Bevins CL, Salzman NH . Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiology 2011; 9: 356–368.
Pott J, Hornef M . Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep 2012; 13: 684–698.
Hooper LV, Macpherson AJ . Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10: 159–169.
Macpherson AJ, Geuking MB, Slack E, Hapfelmeier S, McCoy KD . The habitat, double life, citizenship, and forgetfulness of IgA. Immunol Rev 2012; 245: 132–146.
Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GM, Neyrinck AM et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60: 2775–2786.
Kitazawa H, Nishihara T, Nambu T, Nishizawa H, Iwaki M, Fukuhara A et al. Intectin, a novel small intestine-specific glycosylphosphatidylinositol-anchored protein, accelerates apoptosis of intestinal epithelial cells. J Biol Chem 2004; 279: 42867–42874.
Everard A, Lazarevic V, Gaia N, Johansson M, Stahlman M, Backhed F et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 2014; 8: 2116–2130.
Vereecke L, Beyaert R, van Loo G . Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol Med 2011; 17: 584–593.
Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C, Grencis RK . Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005; 308: 1463–1465.
Duparc T, Plovier H, Marrachelli VG, Van Hul M, Essaghir A, Stahlman M et al. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. Gut 2016. e-pub ahead of print 5 May 2016 doi:10.1136/gutjnl-2015-310904..
Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun 2014; 5: 5648.
Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, Delzenne NM et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6: 392.
Alhouayek M, Lambert DM, Delzenne NM, Cani PD, Muccioli GG . Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J 2011; 25: 2711–2721.
Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z et al. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 1998; 353: 23–31.
Hansen KB, Rosenkilde MM, Knop FK, Wellner N, Diep TA, Rehfeld JF et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab 2011; 96: E1409–E1417.
Geurts L, Everard A, Van Hul M, Essaghir A, Duparc T, Matamoros S et al. Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. Nat Commun 2015; 6: 6495.
Acknowledgements
PDC is a research associate at the FRS-FNRS (Fonds de la Recherche Scientifique), Belgium. PDC is a recipient of an ERC Starting Grant 2013 (European Research Council, Starting grant 336452-ENIGMO and PoC ERC 2015), FNRS grants (T0.138.14; J.0084.15), the Funds Baillet-Latour (grant for medical research 2015), FNRS for the FRFS-WELBIO under grant: WELBIO-CR-2012S-02R and ARC (Concerted Research Activities-French Community of Belgium convention: 12/17-047). Publication of this article was sponsored by the Université Laval’s Research Chair in Obesity in an effort to inform the public on the causes, consequences, treatments and prevention of obesity.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
PDC has received consulting and lecture fees for Biocodex, Bioaster, Tate & Lyle, Pileje, J&J.
Rights and permissions
About this article
Cite this article
Cani, P. Interactions between gut microbes and host cells control gut barrier and metabolism. Int J Obes Supp 6 (Suppl 1), S28–S31 (2016). https://doi.org/10.1038/ijosup.2016.6
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijosup.2016.6
This article is cited by
-
Lactobacillus rhamnosus GG ameliorates DON-induced intestinal damage depending on the enrichment of beneficial bacteria in weaned piglets
Journal of Animal Science and Biotechnology (2022)
-
Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate
Nature Communications (2022)
-
Fenofibrate promotes PPARα-targeted recovery of the intestinal epithelial barrier at the host-microbe interface in dogs with diabetes mellitus
Scientific Reports (2021)